Page 6 - ஆம்ஸ்டர்டாம் பல்கலைக்கழகம் மருத்துவ மையங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Om een nier te donoren moet je fit zijn
dwtonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dwtonline.com Daily Mail and Mail on Sunday newspapers.
- DWTonline com
dwtonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dwtonline.com Daily Mail and Mail on Sunday newspapers.
February 23, 2021
Most men with prostate cancer who are treated with medical castration, also called androgen-deprivation therapy, will have an increase in QT interval, with torsade de pointes and ventricular fibrillation developing in rare cases, retrospective data affirm.
At a single Japanese center, QT interval corrected for heart rate (QTc) was prolonged in 79.9% of patients during therapy, according to researchers led by Kanae Hasegawa, MD, PhD (University of Fukui, Japan). The QT interval increased by an average of 12 ms, and the QTc by an average of 23 ms (
P 0.001 for both).
Two patients (1.3%), neither of whom had known CVD risks, developed torsade de pointes/ventricular fibrillation, the investigators report in a study recently published online in the
Press release content from Business Wire. The AP news staff was not involved in its creation.
TransEnterix Announces New Training Center in EU
February 18, 2021 GMT
RESEARCH TRIANGLE PARK, N.C. (BUSINESS WIRE) Feb 18, 2021
TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company has agreed to partner with the Amsterdam Skills Centre (ASC) in the Netherlands for surgical training. This site will serve surgeons and staff throughout Europe with basic and advanced training on the Senhance® Surgical System. The ASC will also provide TransEnterix with a world-class facility to engage European surgeons in technology and clinical development studies.
TransEnterix, Inc.: TransEnterix Announces New Training Center in EU
Agreement with the Amsterdam Skills Centre Establishes Second European Surgical Training Site for Senhance Digital Laparoscopy
TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company has agreed to partner with the Amsterdam Skills Centre (ASC) in the Netherlands for surgical training. This site will serve surgeons and staff throughout Europe with basic and advanced training on the Senhance Surgical System. The ASC will also provide TransEnterix with a world-class facility to engage European surgeons in technology and clinical development studies.
vimarsana © 2020. All Rights Reserved.